LFST vs REGN · P/E 146, rev $1.25B vs P/E 14, rev $14.34B
Lifestance Health Group Inc (LFST) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Lifestance Health Group Inc (LFST) is a medical care facilities company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported LFST revenue for 2024-12-31 was $1.25B. Net income was -$57.4M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. LFST currently screens at market cap $3.35B and trailing P/E 146.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
LFST currently screens at market cap $3.35B and trailing P/E 146.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the LFST and REGN stock pages for the full models.
Not investment advice.